Go to the newsletter page and sign up to receive course dates, call for applications and other related programme news.
Medical Oncology II
Module 6 - Enhance expertise in medical oncology: refine skills in chemotherapy administration, manage adverse effects, and integrate multimodal therapeutic approaches effectively.
This course is a part of
Companion Animal ONCOLOGY - Advanced course - Module 6
The purpose of this course is to provide experience and expertise in the medical and multimodality management of companion animal cancer patients including indications for, planning of and administration of single and multiagent chemotherapy for the most commonly treated companion animal cancers and the principles and role of radiotherapy.
The mechanism of action, principles of use of cytostatic drugs as well as the administration as either single agent or multi agent protocols or as part of multimodality approaches in the treatment of the most common companion animal cancers will be part of this module.
Furthermore classification, monitoring and prevention and management of chemotherapy adverse effects according to the guidelines established by VCOG (Veterinary Comparative Oncology Group).
Each participant makes procedures for the treatment protocols used to treat the most common companion animal medical oncology patients for their own practice.
For more details about the course, please refer to the course curriculum.
Read more about the specialisation tracks and the Master's programme on the main page:
Course Directors on Medical Oncology II
Maja ArendtAssociate Professor |
Course details on Medical Oncology II
Dates and examination
Course dates 2026
13-17 April 2026
Course dates 2028
18-22 April 2028*
*Tuesday-Saturday due to national holiday
The course is available every second year
Examination
Please find dates and details about the exam in the exam schedule.
Learning outcomes
Having completed the course, the student must be able to:
Knowledge
- Describe and reflect about common ethical, safety, and environmental considerations in treatment with cytostatic drugs in companion animal cancer patients.
- Define, identify and demonstrate overview of commonly used companion animal cancer chemotherapy protocols and multimodality approaches to therapeutic management.
- List, classify, and demonstrate critical reflection on existing and new medical or combined approaches to oncology patient therapy and client education.
- Demonstrate appropriate understanding regarding nutrition, nutraceuticals and supplementary therapies in veterinary cancer patients.
- Be current on specific blood product transfusion-guidelines and demonstrate an understanding of hemostatic disorders in veterinary cancer patients.
- Have an in depth knowledge of cancer related pain.
- Understand the use of radiotherapy in veterinary cancer patients for their own practice.
Skills
- Use appropriate procedures and administration protocols for medical management and follow up of specific companion animal cancer types.
- Interpret, assess and reflect on stage and grade of cancer in relation to planning of the therapeutic approach incl. which modalities, protocol and the administration of chemotherapy in individual patients.
- Plan, apply and integrate new evidence based scientific approaches to plan and administer medical therapy in companion animal cancer patients, pain management, nutritional management and other supportive therapy.
- Detect, assess and address adverse effects to cancer chemotherapy effectively and in a timely fashion.
- Communicate effectively in writing and pass on therapeutic results to relevant parties.
Competences
- Evaluate and manage the medical therapy of companion animal cancer patients which may necessitate novel solutions and approaches identified from current medical literature or other ressources as they pertain to the individual patient.
- Work independently, take responsibility for, predict, and prognosticate based on response to therapy for commonly medically treated companion animal cancers.
- Collaborate constructively within and between specialists/professionals and lay persons involved in companion animal medical cancer treatment.
- Independently evaluate and structure own learning processes and continuously obtain new knowledge within the medical management of companion animal cancer patients.
Admission criteria
You must meet the following criteria to be admitted to this course:
- Hold a degree in Veterinary Medicine.
- Hold one of the following certifications:
- DVA Certificate in Small Animal Diseases (equivalent to the 4 compulsory courses of the Master of Companion Animal Clinical Science).
- Swedish / Norwegian / Finnish specialist in diseases of dogs and cats.
- Equivalent competences.
- Have a minimum of 2 years of relevant work experience from companion animal practice.
- Be proficient in English.
Find detailed information about the formal requirements for this course.
Read more about admission on the main page of Master of Companion Animal Clinical Science.
Tuition fees
EU/EEA citizens*
Single course student: 33,500 DKK
Master student: 30,000 DKK
Non-EU/EEA citizens
Single course student: 37,740 DKK
Master student: 34,240 DKK
Tuition fees include course materials and lunch/coffee. Books are not included in the tuition fees and must be purchased by the participants.
*Citizens of the EU, EEA or Switzerland is entitled to a subsidised tuition fee, due to EU legislation, hence the difference in price.
Location
University of Copenhagen
University Hospital for Companion Animals
Dyrlægevej 16
1958 Frederiksberg
Denmark
Contact
Christine Gulstad
Study Administration Officer
Tel.: +45 35 32 12 73
Maja Arendt
Associate Professor
DVM, PhD, DipESVONC